Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled date : 2021 - 06 - 01 save search
Halozyme Highlights Data Presentations by Collaborators for Therapies Utilizing ENHANZE® at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2021-06-01 (Crawled : 21:00) - halozyme.com
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 0.05%
H: 0.7%
C: -5.31%
presentation therapy collaboration
Immutep Enters Into A New Collaboration With Merck KGaA, Darmstadt, Germany For LAG-3 Therapy, Efti
Published: 2021-06-01 (Crawled : 16:00) - biospace.com/
IMMP | $2.25 2.27% 2.22% 90K
|
Health Technology
|
| O: 6.35%
H: 1.43%
C: -2.8%
therapy collaboration germany
Nationwide Access to Ultrafiltration Therapy Possible with Nuwellis and Premier, Inc. Collaboration
Published: 2021-06-01 (Crawled : 14:00) - globenewswire.com
NUWE | $0.255 -2.07% -2.12% 230K
|
Manufacturing
|
| O: 1.99%
H: 31.46%
C: 7.56%
PINC | $21.18 1.88% 1.84% 1.1M
|
Health Services
|
| O: 0.7%
H: 0.27%
C: -0.96%
therapy collaboration
Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
Published: 2021-06-01 (Crawled : 14:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.53%
H: 0.03%
C: -2.72%
treatment fda therapy breakthrough therapy grant designation
BeyondSpring Announces U.S. FDA Acceptance and Priority Review of New Drug Application for Plinabulin and G-CSF Combination for the Prevention of Chemotherapy-Induced Neutropenia (CIN)
Published: 2021-06-01 (Crawled : 12:00) - biospace.com/
BYSI | $1.8 -2.21% 80K
|
Health Technology
|
| O: 5.74%
H: 9.07%
C: 4.51%
new drug fda fda acceptance therapy drug plinabulin
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.